National Academies Press: OpenBook

Venture Funding and the NIH SBIR Program (2009)

Chapter: Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource

« Previous: Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Appendix D
Venture-funded Firms: Data from Hoover’s Small Business Database and VentureSource

Company

Venture Capital (Thousands of Dollars)

Rounds

Last Round Date

Advanced Tissue Sciences, Inc.

90,578.0

3

11/2/2001

Albion Instruments

8,968.0

7

1/1/1990

Ambion, Inc.

10,500.0

1

5/1/2003

Applied Immune Sciences, Inc.

44,060.1

11

1/1/1991

Applied Molecular Evolution, Inc.

32,350.0

6

6/1/2000

Aronex Pharmaceuticals, Inc.

9,496.0

3

3/2/1999

Aviron (FKA: Vector Pharmaceuticals, Inc.)

87,340.1

4

11/1/2000

Argus Software, Inc.

3,815.9

4

7/30/1999

Aurora Biosciences Corporation

18,720.0

3

12/15/1996

AcryMed, Inc.

3,500.0

4

3/1/2003

Alexion Pharmaceuticals, Inc.

5,800.0

2

12/23/1994

Automatix, Inc.

21,850.0

7

12/1/1987

Aastrom Biosciences, Inc.

36,384.9

8

10/30/2002

ABIOMED, Inc.

35,800.0

1

3/27/2007

Adolor Corporation

137,483.0

7

5/31/2001

Alkermes, Inc.

12,384.3

5

10/1/1992

Amylin Pharmaceuticals, Inc.

84,200.0

9

9/20/2002

ARIAD Pharmaceuticals, Inc.

56,075.0

3

5/20/2003

Aradigm Corporation

139,454.0

9

3/7/2003

Altea Therapeutics

54,546.9

4

6/15/2007

Amedica Corporation

44,569.0

4

4/27/2007

Amnis Corporation

18,750.0

3

3/27/2006

Ancile Pharmaceuticals, Inc.

30,365.0

6

10/27/2002

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

First Round Date

Status

Ticker Symbol

Last Known Date

Annual Revenue (Millions of Dollars)

Number of Employees

Profit/Loss

4/1/1996

Out of business

 

2003

 

 

 

6/1/1986

Sold

 

2000

 

 

 

5/1/2003

Sold

 

2006

13.6

 

 

11/1/1984

Sold

 

1995

 

 

 

3/1/1990

Sold

 

 

10.2

 

 

7/1/1991

Sold

 

2001

 

 

 

6/1/1992

Sold

 

 

 

 

 

1/1/1995

Foreign

 

 

 

 

 

3/7/1996

Foreign

 

 

 

 

 

4/1/1994

n/a

 

 

 

 

 

11/12/1993

NASDAQ

ALXN

 

1.6

241

(131.5)

1/1/1980

n/a

 

 

 

 

 

8/18/1989

NASDAQ

ASTM

 

0.7

 

(17.6)

3/27/2007

NASDAQ

AMMD

 

50.7

324

 

11/1/1994

NASDAQ

ADLR

 

15.9

179

(69.7)

10/1/1987

NASDAQ

alks

 

240.0

830

9.9

11/1/1987

NASDAQ

AMLN

 

510.9

1,550

(218.9)

2/1/1991

NASDAQ

ARIA

 

0.9

108

(61.9)

10/16/1992

OTC

ARDM

 

4.8

103

(13.0)

11/21/2002

private

 

 

 

 

 

1/28/2004

private

failed IPO

2007

0.1

33

(6.3)

2/28/2000

private

 

 

3.5

37

 

11/4/1998

private

 

 

3.2

30

 

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Company

Venture Capital (Thousands of Dollars)

Rounds

Last Round Date

Artecel Sciences, Inc.

4,135.2

2

5/29/2002

Atherotech, Inc.

21,399.9

4

1/31/2005

Avocet Medical, Inc.

36,801.0

3

7/1/2001

BioCryst Pharmaceuticals, Inc.

39,964.9

3

9/30/2007

BioMarin Pharmaceutical, Inc.

53,000.0

2

5/16/2001

BIOQUAL, Inc. (FKA: Diagnon Corporation)

1,351.0

2

5/1/1983

Biosearch, Inc.

1,800.0

2

12/1/1983

Biosym Technologies, Inc.

5,168.0

3

4/1/1992

BioTransplant, Inc.

9,561.0

3

6/30/2001

Cambridge Neuroscience, Inc. (FKA: Synax, Inc.)

35,879.0

9

6/21/1997

Cell Based Delivery, Inc.

11,175.0

2

5/7/2002

Centaur Pharmaceuticals, Inc.

63,451.0

7

11/2/2001

Cephalon, Inc.

40,037.8

8

2/25/1999

Chektec Corporation

846.0

3

4/1/1993

Clarus Medical LLC (Medilase, Inc.)

27,548.9

12

5/1/1997

Clontech Laboratories, Inc.

28,836.0

2

7/1/1998

CoCensys, Inc.

24,071.0

9

1/7/1997

Cognetix, Inc.

19,010.0

2

6/1/2006

CompuCyte Corporation

18,700.0

3

8/1/1999

Conductus, Inc.

45,699.9

6

3/27/2002

Control Delivery Systems, Inc. (AKA: CDS, Inc.)

34,500.0

1

8/22/2000

COR Therapeutics, Inc.

20,652.0

6

1/1/1998

Corixa Corporation

157,581.1

6

6/10/2003

Cortex Pharmaceuticals, Inc.

9,100.0

2

7/1/1989

Creative BioMolecules, Inc.

23,284.0

18

7/1/1995

Cryolife, Inc.

3,057.0

3

6/1/1988

Cryopharm Corporation

30,346.0

10

1/1/1994

Cubist Pharmaceuticals, Inc.

36,283.0

5

9/23/1998

CuraGen Corporation

26,790.0

2

9/1/1999

CytoLogix Corporation

46,850.0

5

5/29/2002

Cytomation, Inc.

14,293.0

2

6/8/2001

Cytyc Corporation (FKA: Generitech Corporation)

35,154.9

4

5/1/1995

Dharmacon Research, Inc.

5,700.0

1

8/23/2002

Digirad Corporation (FKA: Aurora Technologies)

75,320.0

9

4/24/2002

DiscoveRx Corporation, Ltd.

28,406.0

5

2/20/2007

Discovery Laboratories, Inc.

13,211.0

2

6/20/2003

Displaytech, Inc.

70,225.1

5

3/12/2006

Edenspace Systems Corporation

5,250.0

1

4/23/2007

EKOS Corporation

85,900.4

8

6/27/2007

Endocyte, Inc.

60,700.2

4

3/23/2007

Epicyte Pharmaceutical, Inc.

22,200.0

4

4/16/2001

EpiGenesis Pharmaceuticals, Inc.

35,956.2

4

3/7/2007

Epoch Biosciences (FKA:MicroProbe Corporation)

30,030.2

13

7/1/1993

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

First Round Date

Status

Ticker Symbol

Last Known Date

Annual Revenue (Millions of Dollars)

Number of Employees

Profit/Loss

11/29/2000

private

 

 

0.1

1

 

3/31/1999

private

 

 

 

 

 

10/1/1996

private

 

 

 

 

 

8/1/1992

NASDAQ

 

 

6.2

52

(43.6)

1/1/1998

NASDAQ

 

 

84.2

314

(28.5)

7/1/1981

private

 

 

19.4

150

 

4/1/1983

private

 

 

4.6

65

 

10/1/1986

Sold

 

 

 

 

 

10/1/1995

Out of business

 

2003

 

 

 

1/1/1986

Sold

 

 

 

 

 

3/7/2002

Out of business

 

 

 

 

 

12/1/1992

Out of business

 

2002

 

 

 

10/1/1987

NASDAQ

CEPH

 

18,641.1

2,895

144.8

12/1/1988

Outof business

 

 

 

 

 

1/6/1989

private

 

 

0.2

3

 

7/1/1997

private

 

 

17.0

175

 

2/1/1989

Sold

 

 

 

 

 

8/1/2001

Out of business

 

 

 

 

 

4/1/1996

private

 

 

6.7

28

 

9/1/1987

Sold

 

 

 

 

 

8/22/2000

Sold

 

2005

17.2

26

 

3/16/1988

Sold

 

2002

 

 

 

12/2/1994

Sold

 

2005

 

 

 

5/1/1988

AMEX

COR

 

1.2

26

(16.2)

5/1/1982

NASDAQ

CRIS

 

16.7

68

(8.8)

1/1/1986

NYSE

CRY

 

81.3

363

0.4

1/1/1988

private

 

 

2.5

25

 

9/1/1992

NASDAQ

CBST

 

194.8

410

(0.4)

3/1/1997

NASDAQ

CRGN

 

39.6

666

(59.8)

1/1/1997

private

 

 

 

 

 

5/1/1997

Sold

 

 

 

 

 

1/1/1987

Sold

 

2006

608.0

1,500

139.5

8/23/2002

private

 

 

10.1

120

 

5/30/1995

NASDAQ

DRAD

 

71.9

601

(6.3)

2/1/1999

private

 

 

3.3

40

 

11/5/2002

NASDAQ

 

 

0.0

160

(46.3)

4/11/2000

IPO

 

2002

3.2

47

 

4/23/2007

private

 

 

0.7

10

 

10/1/1996

private

 

 

9.5

99

 

7/1/2001

private

 

 

3.3

40

 

7/1/1996

Sold

 

2004

 

 

 

10/1/1997

private

 

 

 

 

 

3/1/1986

Sold

 

2004

 

 

 

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Company

Venture Capital (Thousands of Dollars)

Rounds

Last Round Date

EraGen Biosciences, Inc. (FKA: Sulfonics, Inc.)

32,647.0

3

3/15/2007

Exogene Corporation

7,115.1

5

7/1/1993

Fluorous Technologies, Inc. (AKA: FTI)

3,650.0

2

5/23/2003

Genaera Corporation (FKA: Magainin Pharmaceuticals)

18,106.0

5

10/1/1998

Genaissance Pharmaceuticals, Inc.

75,749.9

4

11/4/2004

Genelabs Technologies, Inc.

34,949.4

8

6/29/2006

GeneMedicine, Inc.

8,900.0

2

7/13/1994

Genetic Therapy, Inc.

13,989.0

8

7/1/1994

GenPharm International, Inc.

18,989.1

8

2/29/2000

Geron Corporation

42,074.8

5

1/1/1996

Gilead Sciences, Inc.

32,060.0

6

8/1/1992

Gliatech, Inc.

32,596.1

7

6/1/1995

Hauser Chemical Research, Inc.

1,893.0

3

12/7/1990

Hawaii Biotech, Inc.

16,500.0

5

12/26/2006

Houston Biotechnology, Inc.

3,240.0

2

5/1/1986

Hypres, Inc.

39,841.0

20

12/31/2002

Icagen, Inc.

96,700.7

7

2/1/2007

Illumigen Biosciences, Inc.

7,950.0

8

7/6/2007

Illumina, Inc.

36,567.0

2

11/1/1999

Immtech Pharmaceuticals, Inc. (FKA: Immtech International)

2,509.0

3

2/14/1994

ImmuLogic Pharmaceutical Corporation

29,844.0

5

2/22/1993

Immunicon Corporation

106,800.4

7

6/29/2005

ImmunoGen, Inc.

21,934.0

7

1/1/1989

Immusol, Inc.

23,500.0

2

9/24/2003

IntraTherapeutics, Inc. (FKA: Cardia Catheter Company)

32,224.2

8

3/31/2000

Invitrogen Corporation

15,000.0

1

6/20/1997

Iomai Corporation

80,570.0

9

10/25/2006

Irvine Sensors Corporation

2,650.0

3

6/10/2003

Isis Pharmaceuticals

17,490.0

6

8/11/1994

Isolab, Inc.

2,744.0

2

6/28/1990

ISTO Technologies, Inc.

25,725.0

5

8/3/2007

Kurzweil Applied Intelligence, Inc.

26,122.1

13

1/1/1993

Large Scale Biology Corp. (FKA: Biosource Genetics Corp)

11,675.1

6

3/1/1998

Laser Diagnostic Technology, Inc.

13,310.9

5

11/30/2001

Laserscope

24,045.4

8

9/1/1987

LeukoSite, Inc.

32,613.1

8

7/1/1998

LifeSpan BioSciences, Inc.

19,000.0

1

4/17/2001

Linguagen Corporation

20,212.0

4

5/23/2006

Lucent Medical Systems, Inc.

6,700.0

2

9/25/1998

Lynx Therapeutics, Inc.

72,200.4

5

9/25/2003

Markwell Medical Institute, Inc.

882.0

5

5/1/1987

MediChem Research Inc.

35,000.0

1

6/28/1999

Medinox, Inc.

21,199.8

2

1/8/2002

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

First Round Date

Status

Ticker Symbol

Last Known Date

Annual Revenue (Millions of Dollars)

Number of Employees

Profit/Loss

10/6/2005

private

 

 

 

 

 

10/1/1988

Sold

 

1996

 

 

 

6/20/2000

private

 

 

2.0

15

 

3/1/1988

NASDAQ

GENR

 

0.9

46

(21.2)

8/1/1998

Sold

 

2005

 

 

 

10/1/1984

NASDAQ

GNLB

 

11.2

66

(8.7)

10/1/1992

private

 

 

14.9

110

 

8/1/1988

private

 

 

1.0

15

 

2/29/2000

Sold

 

 

 

 

 

7/10/1992

NASDAQ

GERN

 

3.3

90

(31.4)

8/1/1987

NASDAQ

GILD

 

3,026.1

2,525

(1,190.0)

7/1/1988

Sold

 

2000

 

 

 

4/1/1988

Out of business

 

 

 

 

 

6/7/2002

private

 

 

5.1

65

 

10/1/1985

Sold

 

 

 

 

 

7/1/1983

private

 

 

8.0

33

 

10/1/1995

NASDAQ

ICGN

 

8.4

72

(24.8)

5/1/2000

private

 

 

1.5

10

 

11/30/1998

NASDAQ

ILMN

 

184.5

277

40.0

12/21/1992

AMEX

IMM

 

4.3

27

(11.3)

5/1/1987

Out of business

 

2002

 

 

 

7/1/1988

NASDAQ

IMMC

 

8.7

107

(24.0)

6/1/1981

NASDAQ

IMGN

 

38.2

192

(19.0)

6/1/2001

Sold

 

 

 

 

 

10/7/1991

Sold

 

2001

 

 

 

6/20/1997

NASDAQ

 

 

1,263.5

4,835

(191.0)

1/1/1998

NASDAQ

IOMI

 

1.5

66

(31.8)

10/1/1997

NASDAQ

IRSN

 

30.8

166

(8.5)

2/1/1989

NASDAQ

ISIS

 

24.5

258

(45.9)

5/1/1987

Foreign

 

 

 

 

 

3/1/2000

private

 

 

1.6

24

 

5/1/1984

private

 

 

 

 

 

12/1/1987

private

 

 

0.8

20

 

1/1/1994

Foreign

 

 

 

 

 

3/1/1983

Sold

 

2006

 

 

 

9/1/1994

Sold

 

1999

 

 

 

4/17/2001

private

 

 

3.3

40

 

12/30/2003

private

 

 

 

 

 

7/1/1997

private

 

 

0.5

7

 

2/15/1994

Sold

2007

 

 

 

6/1/1981

Out of business

 

 

 

 

 

6/28/1999

private

 

 

 

 

 

6/15/1999

private

 

 

 

 

 

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Company

Venture Capital (Thousands of Dollars)

Rounds

Last Round Date

MediSpectra, Inc.

58,970.0

8

7/21/2006

Meridian Instruments, Inc.

3,557.0

4

10/1/1993

Message Pharmaceuticals, Inc.

11,142.5

8

4/14/2004

MIICRO, Inc.

6,840.0

4

9/26/2001

MIDI

2.0

8,250

5/3/2004

Moberg Medical, Inc. (AKA: Moberg Research, Inc.)

5,473.8

6

4/1/1997

Molecular Dynamics, Inc.

22,717.0

7

7/1/1994

Myogen, Inc.

191,452.8

6

10/13/2004

Nanosphere, Inc.

80,130.1

5

5/16/2006

NeoGenesis, Inc.

22,999.9

1

6/21/2001

Nereus Pharmaceuticals, Inc.

127,345.6

8

8/9/2007

NeuroControl Corporation

22,800.0

9

1/4/2001

Neurocrine Biosciences, Inc.

21,499.9

6

5/23/1996

Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals)

28,717.0

4

12/7/2001

NimbleGen Systems, Inc.

73,250.5

8

1/2/2007

Nimbus Medical, Inc.

9,635.1

3

7/1/1986

Octagen Corporation

4,800.0

2

3/6/2000

Ontogen

24,945.0

5

10/13/2000

Onyx Pharmaceuticals, Inc.

70,200.2

6

5/9/2002

Organ Recovery Systems

13,999.8

1

7/29/2004

Orquest, Inc.

42,814.8

5

10/16/2001

Palatin Technologies

45,700.0

3

1/30/2004

Panacos Pharmaceuticals, Inc.

26,550.0

3

6/28/2007

Perlan Therapeutics, Inc.

5,227.0

3

12/27/2001

Pharmacopeia Drug Discovery, Inc.

8,472.0

1

8/11/2005

PharmaSonics, Inc.

22,700.0

4

6/30/2002

Pharmavene, Inc.

13,044.0

3

6/1/1996

PHT Corporation (AKA: Personal Health Technologies Corp.)

48,250.2

6

10/18/2004

Phylos, Inc.

25,100.0

1

11/30/2000

Physical Optics Corporation

3,337.0

4

8/1/1990

Physical Sciences, Inc.

492.0

2

7/1/1995

Premier Laser Systems, Inc

6,145.0

4

1/1/1997

Progenics Pharmaceuticals, Inc.

21,448.0

2

12/27/2005

Promega Corporation

5,250.0

4

5/27/1993

PRP, Inc.

384.0

2

1/1/1996

Proteome, Inc.

8,100.0

1

12/1/1999

Quantum Dot Corporation (AKA: Q Dot)

39,150.0

3

8/10/2005

Quantum Magnetics, Inc.

3,800.0

3

7/1/1997

Replidyne, Inc.

126,500.1

6

8/17/2005

Repligen Corporation

12,234.0

3

5/1/1985

RiboGene, Inc. (FKA: Transgene)

48,233.2

15

2/1/1997

Sangamo Biosciences

16,950.0

3

12/31/2001

Sangart, Inc.

50,353.0

2

4/4/2007

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

First Round Date

Status

Ticker Symbol

Last Known Date

Annual Revenue (Millions of Dollars)

Number of Employees

Profit/Loss

6/1/1996

private

 

 

1.6

21

 

5/1/1983

Sold

 

 

 

 

 

1/1/1998

Out of business

 

2004

 

 

 

10/31/1997

private

 

 

1.6

20

 

5/19/2005

private

 

 

1.3

25

 

1/1/1992

private

 

 

 

 

 

9/1/1987

Sold

 

1998

 

 

 

10/5/1998

Sold

 

2006

 

 

 

1/25/2000

NASDAQ

NSPH

 

1.1

50

113.0

1/9/2001

Sold

 

2005

 

 

 

7/29/1998

private

 

 

9.3

29

 

3/3/1994

private

 

 

 

 

 

9/25/1992

NASDAQ

NBIX

 

39.2

588

(107.2)

10/1/1998

private

 

 

 

 

 

9/1/2000

Sold

 

 

 

 

 

3/1/1988

Sold

 

1996

 

 

 

4/1/1998

private

 

 

 

 

 

5/19/1992

Out of business

 

2003

 

 

 

4/24/1992

NASDAQ

 

 

0.3

125

(92.7)

1/20/2003

private

 

 

2.4

27

 

6/8/1994

Sold

 

2003

 

 

 

11/1/1996

AMEX

PTN

 

14.4

85

(27.8)

11/4/2000

NASDAQ

PANC

 

0.3

32

(38.1)

6/4/1999

private

 

 

1.2

14

 

8/11/2005

NASDAQ

PCOP

 

16.9

150

(27.8)

2/1/1997

Out of business

 

 

 

 

 

4/1/1993

Sold

 

 

 

 

 

11/3/1999

private

 

 

8.4

80

 

11/30/2000

private

 

 

1.7

18

 

8/1/1987

private

 

 

30.0

150

 

5/9/1995

private

 

 

12.4

150

 

4/1/1994

Out of business

 

 

 

 

 

12/1/1995

NASDAQ

PGNX

 

69.9

149

(21.6)

10/1/1982

private

 

 

175.0

850

 

4/1/1996

private

 

 

6.8

130

 

12/1/1999

private

 

 

 

 

 

1/1/1999

Sold

 

2005

 

 

 

10/15/1995

Out of business

 

 

 

 

 

2/21/2002

NASDAQ

RDYN

 

16.0

85

(29.3)

11/1/1981

NASDAQ

RGEN

 

14.1

45

(0.9)

1/1/1990

Sold

 

1999

 

 

 

6/1/1996

NASDAQ

SGMO

 

7.9

62

(17.9)

10/31/2004

private

 

 

7.3

35

 

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Company

Venture Capital (Thousands of Dollars)

Rounds

Last Round Date

Scios Nova, Inc. (F.K.A Scios Inc) California Biotechnology)

5,425.0

1

6/1/1982

Secretech

800.0

2

10/1/1990

Selective Genetics, Inc. (FKA: Prizm Pharmaceuticals, Inc.)

56,867.0

14

12/1/2003

Sepracor, Inc.

16,892.0

8

2/22/1993

Signal Pharmaceuticals, Inc.

44,543.7

10

12/1/1999

Spire Corporation

3,750.0

3

1/1/1987

Stratagene Cloning Systems

1,873.0

2

12/31/1992

Structural Bioinformatics, Inc.

46,371.7

4

3/22/2000

Sunesis Pharmaceuticals, Inc. (FKA: Mosaic Pharmaceutical)

163,338.1

8

5/30/2007

Synaptic Pharmaceutical Corporation (FKA:Neurogenetic Corp)

89,772.2

7

9/5/2001

T Cell Sciences, Inc.

3,634.0

3

10/1/1989

Targeted Genetics Corporation

46,450.0

4

6/28/2007

TechniScan Medical Systems, Inc.

6,400.0

1

2/5/2007

Tegic Communications, Inc. (AKA:T9 Text Input)

15,000.0

2

5/4/1999

Telefactor Corporation

450.0

3

12/31/1998

Telios Pharmaceuticals, Inc.

30,530.0

7

1/1/1993

Third Wave Technologies, Inc.

78,064.2

5

7/26/2000

TraceDetect, Inc.

1,600.0

2

11/17/2003

TransMolecular, Inc.

42,364.3

4

2/20/2004

Trimeris, Inc. (FKA: SL-1 Pharmaceuticals, Inc.)

38,283.0

6

9/1/1999

United Biomedical, Inc.

9,000.0

1

7/1/1997

UroCor, Inc. (FKA: CytoDiagnostics, Inc.)

16,600.1

5

7/1/1995

VaxGen, Inc.

29,449.0

2

3/1/1997

Vertex Pharmaceuticals, Inc.

13,538.0

5

10/1/1996

VueSonix Sensors

4,600.0

3

7/30/2004

Xeotron Corporation

9,000.0

1

5/1/2001

Xeyex Corporation

3,267.0

2

6/30/1999

Zynaxis, Inc.(FKA: Zynaxis Cell Science/PKH Labs)

37,581.0

8

1/1/1995

Martek Biosciences Corporation

35,167.1

8

1/1/1986

Vestar, Inc.

34,509.1

15

7/1/1981

Vical, Inc.

17,850.0

7

6/1/1987

NOTE: Hoover’s data reflect current data available through Hoover’s Small Business Database as of September 2007.

SOURCES: Data on VC investments are from VentureSource; data on current and historical firms status are from Hoover’s Small Business Database (<http://www.hoovers.com>).

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

First Round Date

Status

Ticker Symbol

Last Known Date

Annual Revenue (Millions of Dollars)

Number of Employees

Profit/Loss

6/1/1982

Sold

 

 

 

 

 

9/1/1989

Out of business

 

 

 

 

 

6/12/1992

private

 

 

 

 

 

1/1/1984

NASDAQ

SEPR

 

1,196.5

228

184.6

1/1/1993

private

 

 

48.5

134

 

11/1/1979

NASDAQ

SPIR

 

20.1

118

(8.1)

4/1/1987

Sold

 

 

 

 

 

11/1/1996

Sold

 

 

 

 

 

2/17/1998

NASDAQ

SNSS

 

13.7

138

 

1/1/1987

Sold

 

 

 

 

 

4/1/1985

Out of business

 

 

 

 

 

6/1/1992

NASDAQ

TGEN

 

9.9

95

(34.0)

2/5/2007

private

 

 

 

 

 

1/22/1998

Sold

 

 

 

 

 

12/31/1997

Sold

 

2000

 

 

 

1/1/1986

Sold

 

 

 

 

 

6/30/1995

NASDAQ

TWTI

 

28.0

154

(18.9)

3/15/2002

private

 

 

1.4

12

 

9/30/1997

private

 

 

1.2

18

 

2/12/1993

NASDAQ

TRMS

 

37.0

90

7.4

7/1/1997

private

 

 

13.8

285

 

7/1/1987

Sold

 

 

 

 

 

4/10/1996

private

 

 

 

 

 

1/1/1989

NASDAQ

TRTX

 

216.4

320

(206.9)

6/9/2000

private

 

 

 

 

 

5/1/2001

Sold

 

2004

 

 

 

1/1/1997

Out of business

 

 

 

 

 

6/1/1988

Out of business

 

 

 

 

 

2/1/2005

NASDAQ

MATK

 

270.0

582

14.9

7/1/1993

Out of business

 

2000

 

 

 

3/10/1993

NASDAQ

VICL

 

14.7

155

(23.1)

Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 82
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 83
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 84
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 85
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 86
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 87
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 88
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 89
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 90
Suggested Citation:"Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 91
Next: Appendix E: Analysis of the Evidence Submitted by BIO »
Venture Funding and the NIH SBIR Program Get This Book
×
Buy Paperback | $34.50 Buy Ebook | $27.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The Small Business Administration issued a policy directive in 2002, the effect of which has been to exclude innovative small firms in which venture capital firms have a controlling interest from the SBIR program. This book seeks to illuminate the consequences of the SBA ruling excluding majority-owned venture capital firms from participation in SBIR projects.

This book is part of the National Research Council's study to evaluate the SBIR program's quality of research and value to the missions of five government agencies. The other books in the series include:

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!